Quote Level 2 Charts News Trades Historical Financials Wiki Message Board

Rexahn Pharmaceuticals, Inc. (RNN)
$ 0.4979 ▲0.0254 (5.38%)
Volume: 1,451,880
Add RNN To StreamerAdd RNN To Streamer
Add RNN To My StocksAdd RNN To My Stocks
Add RNN Price AlertAdd RNN Price Alert
After Hours
Last Trade 		Last: $ 0.50 ▲ 0.0021 (0.42%)
Bid Ask Last Traded Open Prev Close
- - 7:57:48 PM EST 0.49 0.4979
Day's Range 52-Wk Range Avg Volume EPS P/E
0.4749 - 0.499 0.28 - 0.81 852,000 -0.05 N/A
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
59.46M 119.43M 111.07M N/A N/A
Short Interest Short % of Float Insider B/S Inst % Owned Exchange
2.61M 2.3 % N/A 18 % AMEX
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 0.4665 $ 0.4822 $ 0.4906 $ 0.5063 $ 0.5147
More RNN News

Recent Rexahn Pharmaceuticals, Inc., RNN News
Rexahn Awarded U.S. Patent for Novel Anti-Cancer CompoundsBusiness Wire • Mon Jun 17,2013 8:00 AM
Statement of Changes in Beneficial Ownership (4)Edgar (US Regulatory) • Thu Jun 13,2013 4:45 PM
Statement of Changes in Beneficial Ownership (4)Edgar (US Regulatory) • Thu Jun 13,2013 4:41 PM
Statement of Changes in Beneficial Ownership (4)Edgar (US Regulatory) • Thu Jun 13,2013 4:34 PM
Statement of Changes in Beneficial Ownership (4)Edgar (US Regulatory) • Thu Jun 13,2013 4:28 PM
Statement of Changes in Beneficial Ownership (4)Edgar (US Regulatory) • Thu Jun 13,2013 4:23 PM
Securities Registration: Employee Benefit Plan (s-8)Edgar (US Regulatory) • Tue Jun 11,2013 5:12 PM
Current Report Filing (8-k)Edgar (US Regulatory) • Tue Jun 11,2013 4:58 PM
Rexahn Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap ConferencePR Newswire (US) • Mon May 20,2013 8:00 AM
Quarterly Report (10-q)Edgar (US Regulatory) • Thu May 9,2013 4:12 PM
Current Report Filing (8-k)Edgar (US Regulatory) • Fri Mar 29,2013 2:55 PM
Annual Report (10-k)Edgar (US Regulatory) • Fri Mar 22,2013 4:15 PM
Link to Rexahn Pharmaceuticals, Inc. Stock Price

Rexahn Pharmaceuticals, Inc. Company Description


Rexahn Pharmaceuticals, Inc., is a development stage biopharmaceutical company engaged in the development of novel treatments for cancer to patients. URL: www.rexahn.com

RNN Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y


APPL vs ETF alternatives
ETFsToday3mths1YrYTD
RNN5.38%54.63%38.31%57.31%
SPY0.79%7.20%22.13%13.47%
RWL0.62%7.15%28.39%16.70%
PRF0.80%7.28%28.66%16.22%
IPD1.16%8.64%31.94%12.96%
EPS0.82%6.99%21.69%13.84%
XLY1.02%10.46%29.71%18.19%
SSO1.50%13.96%49.39%28.41%
Most Recent RNN Videos
All Stock Videos | Add a Video